Literature DB >> 944242

Eales' disease with neurological involvement Part 1. Clinical features in 9 patients.

B S Singhal, D K Dastur.   

Abstract

Nine patients with characteristic changes of Eales' disease in the eye in whom there was neurological involvement, have been described. The characteristic neurological picture comprised an acute or subacute myelopathy occurring at an interval of a few weeks to a few years after the eye episode; in only 1 patient was there cerebral involvement without any evidence of myelopathy. Besides the involvement of spinal cord at the dorsal level in the 8 patients, there was evidence of additional lesions in the brain stem in 1 patient and in the cervical cord in another.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 944242     DOI: 10.1016/0022-510x(76)90004-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

Review 1.  Neuro-ophthalmological syndromes for neurologists.

Authors:  G D Perkin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154

2.  Ocular inflammatory changes in established multiple sclerosis.

Authors:  E M Graham; D A Francis; M D Sanders; P Rudge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

3.  Chronic encephalitis and Eales disease.

Authors:  F Weber; B Conrad
Journal:  J Neurol       Date:  1993-05       Impact factor: 4.849

4.  Unusual association of Eales disease with multifocal neurological deficit.

Authors:  G Alfieri; F Barontini; S Brogelli; S Maurri
Journal:  Ital J Neurol Sci       Date:  1984-12

5.  CNS involvement in malignant atrophic papulosis (Kohlmeier-Degos disease): vasculopathy and coagulopathy.

Authors:  D K Dastur; B S Singhal; H J Shroff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-02       Impact factor: 10.154

Review 6.  Multiple sclerosis in India: An overview.

Authors:  Bhim S Singhal; Hemali Advani
Journal:  Ann Indian Acad Neurol       Date:  2015-09       Impact factor: 1.383

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.